» Articles » PMID: 27338547

Impaction of Surgical Margin Status on the Survival Outcome After Surgical Resection of Intrahepatic Cholangiocarcinoma: a Systematic Review and Meta-analysis

Overview
Journal J Surg Res
Specialty General Surgery
Date 2016 Jun 25
PMID 27338547
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Conflicting results about the prognostic value of surgical margin status in patients with intrahepatic cholangiocarcinoma (ICC) have been reported. We aimed to assess the association between surgical margin status and prognosis in ICC through a meta-analysis.

Materials And Methods: We conducted a literature search of the articles evaluating the prognostic value of surgical margin status in patients with ICC. The pooled estimation of the hazard ratio (HR) with the 95% confidence interval (CI) was performed to determine the influence of surgical margin status on the survival outcome.

Results: A total of 21 studies involving 3201 patients were finally included into the meta-analysis. The percentage of patients with positive surgical margin ranged from 7.2% to 75.9% in the enrolled studies. The pooled estimates showed that patients with positive surgical margin had inferior overall survival (HR: 1.864; 95% CI: 1.542-2.252; P < 0.001) and progression-free survival (HR: 2.033; 95% CI: 1.030-4.011; P = 0.041) than patients with negative ones. The subgroup analyses and sensitivity analyses were consistent with the overall results.

Conclusions: Patients with negative surgical margin had significantly favorable overall survival and progression-free survival after surgical resection for ICC. The notion of achieving the R0 resection should be emphasized.

Citing Articles

Resectability and survival outcome in real world practice of 720 cholangiocarcinoma patients: intrahepatic, perihilar and distal cholangiocarcinoma.

Sarkhampee P, Ouransatien W, Lertsawatvicha N, Chansitthichock S, Wattanarath P World J Surg Oncol. 2024; 22(1):314.

PMID: 39605039 PMC: 11600713. DOI: 10.1186/s12957-024-03596-y.


Anatomic Versus Non-anatomic Liver Resection for Intrahepatic Cholangiocarcinoma: A Systematic Review and Patient-Level Meta-Analysis.

Berardi G, Risi L, Muttillo E, Aliseda D, Colasanti M, Ettorre G Ann Surg Oncol. 2024; 31(13):9170-9182.

PMID: 39251512 DOI: 10.1245/s10434-024-16121-y.


Impact of Altered Body Composition on Clinical and Oncological Outcomes in Intrahepatic Cholangiocarcinoma.

Wang G, Otto C, Heij L, Al-Masri T, Dahl E, Heise D J Clin Med. 2023; 12(24).

PMID: 38137817 PMC: 10744221. DOI: 10.3390/jcm12247747.


Preoperative prediction model for microvascular invasion in HBV-related intrahepatic cholangiocarcinoma.

Yu L, Dai M, Lu W, Wang D, Ye T, Xu F BMC Surg. 2023; 23(1):239.

PMID: 37592274 PMC: 10433593. DOI: 10.1186/s12893-023-02139-8.


Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection.

Hassan H, Chakrabarti S, Zemla T, Yin J, Wookey V, Prasai K Eur J Surg Oncol. 2023; 49(11):106994.

PMID: 37524649 PMC: 11552685. DOI: 10.1016/j.ejso.2023.106994.